-
16152-10An inactive control to be used in experiments with AGK2 has IC<sub>50</sub> values greater than 50 µM on SIRT1 and SIRT2 and greater than 5 µM on SIRT3.
-
16152-25An inactive control to be used in experiments with AGK2 has IC<sub>50</sub> values greater than 50 µM on SIRT1 and SIRT2 and greater than 5 µM on SIRT3.
-
16152-5An inactive control to be used in experiments with AGK2 has IC<sub>50</sub> values greater than 50 µM on SIRT1 and SIRT2 and greater than 5 µM on SIRT3.
-
13203-10A melatonin receptor MT1 and MT2 agonist and competitive antagonist of human and porcine 5-HT2Creceptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6).
-
13203-100A melatonin receptor MT1 and MT2 agonist and competitive antagonist of human and porcine 5-HT2Creceptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6).
-
13203-5A melatonin receptor MT1 and MT2 agonist and competitive antagonist of human and porcine 5-HT2Creceptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6).
-
13203-50A melatonin receptor MT1 and MT2 agonist and competitive antagonist of human and porcine 5-HT2Creceptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6).
-
19023-1A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC<sub>50</sub> = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced
-
19023-10A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC<sub>50</sub> = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced
-
19023-25A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC<sub>50</sub> = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced
-
19023-5A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC<sub>50</sub> = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced
-
14050-1AH 6809 is an EP and DP receptor antagonist with nearly equal affinity for the cloned human EP1, EP2, EP3-III, and DP1 receptors. AH 6809 blocks the PGE2-induced accumulation of cAMP in COS cells transfected with the human EP2 receptor.